Analysts think AVDL stock price could increase by 113%
Nov 21, 2024, 12:26 PM
-4.09%
What does AVDL do
Avadel Pharmaceuticals PLC, based in Dublin, specializes in biopharmaceuticals with 154 employees and develops medications like LUMRYZ for narcolepsy. Their drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA.
12 analysts think AVDL stock price will increase by 113.49%. The current median analyst target is $22.95 compared to a current stock price of $10.75. The lowest analysts target is $20.20 and the highest analyst target is $31.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.